Why Xeljanz did not have Renvoq plan

Quote
anonymous said:
Hey numb nuts for brains, Xeljanz does not have indication for Psoriasis..
PSA is 15% share while Otesla is 10% .
First 3yrs Otesla didnt even do anything but create diarrhea , they made fortune w Psoriasis.
2.5 billion bro with RA PSA so no wonder BMS didnt want keep your sorry weak efficacy drug & outcasted it to Amgen
Click to expand...


Don't believe our numbers. We define the "market" the way Pfizer wants to minimize IC payouts. Do a little research outside of our environment and look at what's really going on. Facts:

Xeljanz had indications in the biggest market(RA), PSA and UC(huge) and has been on the market since 2012 and in 9 years sales are now at 2.24billon a year (go look at our 10k).

Otezla has indications in PSO and PSA only. Added together, these aren't equal to RA. They have been on the market since 2014 and in 7 years sales are now at 2.20 billion a year (go look at their 10k).

Look at growth rate and tell me where you think things are going. They have a strong hold on the drug that does not harm so start with it. We have a solid hold on the first JAK, the one that is getting rapidly replaced by the newer, cleaner JAKs.
 




anonymous said:
Don't believe our numbers. We define the "market" the way Pfizer wants to minimize IC payouts. Do a little research outside of our environment and look at what's really going on. Facts:

Xeljanz had indications in the biggest market(RA), PSA and UC(huge) and has been on the market since 2012 and in 9 years sales are now at 2.24billon a year (go look at our 10k).

Otezla has indications in PSO and PSA only. Added together, these aren't equal to RA. They have been on the market since 2014 and in 7 years sales are now at 2.20 billion a year (go look at their 10k).

Look at growth rate and tell me where you think things are going. They have a strong hold on the drug that does not harm so start with it. We have a solid hold on the first JAK, the one that is getting rapidly replaced by the newer, cleaner JAKs.
Click to expand...


I think you are forgetting that we have twice as many reps as Otesla as well, so we're about half as valuable. We do so much less with so much more.

Wonder who Gilead will hire?
 








anonymous said:
I think you are forgetting that we have twice as many reps as Otesla as well, so we're about half as valuable. We do so much less with so much more.

Wonder who Gilead will hire?
Click to expand...
Not many. Gilead mostly hiring Genentech & Amgen reps. They dont value the catering canned marketing reps of Xeljanz.
Also most the Xeljanz reps could not sell a 2 step edit product as most the nation had crappy sales until 2018 when formulary hit many across the US. Before then there were only a few areas that reps had 2SE impact. Most did not.
So why go after Xeljanz reps who can not sell in a Step Edit environment when your product is going to be a 2SE agent?????
That is why Gilead made offers to reps from Companies that can sell in 2 SE environment (Most Pfizer is not one of them)
 




Because the head of marketing at the time & his entire mkt team was Clueless and 9 months later & 10% Nrx share tracking $500million Renvoq is shoving their fist in that big mouth VP making him kiss their feet!
Deserves every loss share for being so arrogant & pompous
 








Arrogant non leader Head of Marketing having his cocky heads in the clouds during Renvoq 1st yr. Now he is VP scrambling for answers being 100pts down on scoreboard.
Sorry leadership , but it is Game Set Match Renvoq..... have nobody to blame, no reps-DMs- anybody but yourself in HQ & your head of Marketing now VP.
Time to start taking Accountability & Responsibility that YOU F up ! Stop blaming reps SOV, calls, program actitivity as excuses.
Take OWNERSHIP no matter how poor it was.

PERIOD END OF STORY.... HIGHS ARE BEHIND YOU SO NOW START PREPARING FOR POST LOE IN 48 MONTHS
 




anonymous said:
Arrogant non leader Head of Marketing having his cocky heads in the clouds during Renvoq 1st yr. Now he is VP scrambling for answers being 100pts down on scoreboard.
Sorry leadership , but it is Game Set Match Renvoq..... have nobody to blame, no reps-DMs- anybody but yourself in HQ & your head of Marketing now VP.
Time to start taking Accountability & Responsibility that YOU F up ! Stop blaming reps SOV, calls, program actitivity as excuses.
Take OWNERSHIP no matter how poor it was.

PERIOD END OF STORY.... HIGHS ARE BEHIND YOU SO NOW START PREPARING FOR POST LOE IN 48 MONTHS
Click to expand...
Liked
 








anonymous said:
Years ago, the pharma companies were controlled by sales and marketing support what sales needed. Today totally different and paying the price
Click to expand...
Some divisions are driven by sales in the field and supporting by marketing , like Oncology & Rare Disease. Xeljanz Derm Vaccines IM are all simple primary care business models driven by Marketing top down. With decision makers who never been reps outside of IM or some none at all.
 




We didnt have a competitive plan because "Trump wanta be mini me" was in charge of marketing & clueless with true leadership.
He is a task manager & that is it.
All he did was follow 50 doc surveys & national trends as he said is not showing what reps are seeing in the field. Then after 6 months in Jan , bam all free good interim care patients flipped over to Payor status with 15% Nrx, now Trump mini me is panicking & blaming Reps/SOV/lack of programs/& now covid 19.
Joke of leadership at the top is why Renvoq is kicking our a$$ like no other product has done in the history of Pfizer.

With Enbrel, Humira came out & we had leadership 15yrs ago to hold onto #1 in RA & keep growing to hit $8 Billion a yr.
Xeljanz same situation w Renvoq but different leadership & different results
 




anonymous said:
We didnt have a competitive plan because "Trump wanta be mini me" was in charge of marketing & clueless with true leadership.
He is a task manager & that is it.
All he did was follow 50 doc surveys & national trends as he said is not showing what reps are seeing in the field. Then after 6 months in Jan , bam all free good interim care patients flipped over to Payor status with 15% Nrx, now Trump mini me is panicking & blaming Reps/SOV/lack of programs/& now covid 19.
Joke of leadership at the top is why Renvoq is kicking our a$$ like no other product has done in the history of Pfizer.

With Enbrel, Humira came out & we had leadership 15yrs ago to hold onto #1 in RA & keep growing to hit $8 Billion a yr.
Xeljanz same situation w Renvoq but different leadership & different results
Click to expand...
Worse preperation of any competitive launch in the history of pharma and history of Corp America. Especially for this Jan 2020 Renvoq ramp up.
 




What is the problem w/VP Lotz? Since when is he 100% responsible for everything from A to Z? The Account Team was responsible for dropping the ball on so many major payor plans.
 




anonymous said:
What is the problem w/VP Lotz? Since when is he 100% responsible for everything from A to Z? The Account Team was responsible for dropping the ball on so many major payor plans.
Click to expand...
News flash- Vice President is top of the chain & over, bufget/goals/payor rebate decisions/marketing forcasts/headcount/ overall makeup of Rev & ROI....
VP & Pres give decision on how much if any they are willing to give up in rebates on payor plan, if any. It is their call & payor team follows orders. All approvals go thru VP as whatever rebate is given hits his bottom line profit & net .

You apparently have never worked in HQ or understand the hierarchy of decision making in pharma . Well at least now you know the basic 101 of pharma decisions & approvals.
LMAO
 




Jeffy the man without a plan (and also without a competitive clue).
Renvoq kicking his assola & smashing him upside his big mouth .
Enjoy their 15% share as in a year it will be 25-30%.
Has to be humbling when highest market share was your 1st day on the job.
Great impact with the primary care business model & culture you employ
 




HQ Leadership kept blowing off field intel from reps thinking their marketing survey, feedback & trends did not show Renvoq as a threat.
All should be fired for acting like Trump w the virus in Feb.
 








anonymous said:
You had me, then you lost me. Keep politics out of it. Our Pres has nothing to do with the topic here.
Click to expand...
Not political at all, but it was a 100% accurate analogy.
Xeljanz Marketing & VP knew from field rep intel how much Renvoq was being written in 2019 at launch for months but ignore the field intel & did not have a plan.
(Trump knew about virus in Dec/Jan from global intel, also chose to ignore & did not have a plan)
Just an analogy thats all
 




anonymous said:
You had me, then you lost me. Keep politics out of it. Our Pres has nothing to do with the topic here.
Click to expand...
Dont see anything political in the posters comment.
The comment did not say Trump has anything to do w Not having a Renvoq plan??? You Trump lovers at all costs crack me up & take everything out of context.
Even you Trump at all costs blow hards must admit, Trump did exact same thing w the virus on National TV & SOTU address... cant run or hide what is on tape....
So it is a Perfect analogy to Xeljanz leaders not having a Renvoq plan.
 








Top Bottom
Back
Quote